TP53 and neoplasm: The high incidence of somatic TP53 mutations in HNSCC has been linked to tumor progression and decreased survival by preventing cytotoxic CD8+ T cell infiltration and encouraging the intra-tumor recruitment of regulatory T cells and M2 macrophages (58).